MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...

Please provide your email address to receive an email when new articles are posted on . Reintervention rates were higher for hysteroscopic myomectomy, uterine artery embolization and endometrial ...

“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...

BERKELEY, Calif.--(BUSINESS WIRE)--Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first ...

Transcervical radiofrequency ablation is a potential minimally invasive alternative for the treatment of symptomatic uterine leiomyomas, also known as fibroids, new research suggests. In the 22-site ...

On March 20, Dr. Mitch Dizon, a subspecialist in Minimally Invasive Gynecologic Surgery at Erlanger Women’s Health, performed the region’s first laparoscopic radiofrequency ablation surgery for ...

About 11 million women in the U.S. are currently diagnosed with uterine fibroids, while 3.7 million undiagnosed women report having symptoms suggestive of uterine fibroids, according to medical tech ...

The Chulabhorn Royal Academy has introduced another major step in improving women's healthcare and fertility, demonstrating how microwave ablation can effectively treat uterine fibroids.The ...

Please provide your email address to receive an email when new articles are posted on . Live birth rates were similar for women with uterine fibroids who underwent radiofrequency ablation or ...

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...